Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03821675 · ClinicalTrials.gov registry record · NA
Electrical Stimulation to Accelerate Wound Healing
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT03821675 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 38 participants.
The verdict
NCT03821675, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
A clinical study at the Baylor College of Medicine, Division of Vascular Surgery and Endovascular Therapy, is being proposed to test the efficacy of a novel electrical stimulation platform named the Tennant Biomodulator designed by AVAZZIA to accelerate wound healing, relieve pain and improve mobility in patients with diabetic foot ulcers.
Interventions
- DEVICE Electrical Stimulation - Sham
- DEVICE Electrical Stimulation - Active
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-02-28 |
| Est. Completion | 2021-10-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03821675
The ClinicalTrials.gov registry entry for NCT03821675 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electrical Stimulation - Sham is the first listed.
NCT03821675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03821675 about?
NCT03821675 is a clinical study titled "Electrical Stimulation to Accelerate Wound Healing". A clinical study at the Baylor College of Medicine, Division of Vascular Surgery and Endovascular Therapy, is being proposed to test the efficacy of a novel electrical stimulation platform named the Tennant Biomodulator designed by AVAZZIA to accelerate wound healing, relieve pain and improve mobili...
What is the current status of trial NCT03821675?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2019-02-28. Estimated completion is 2021-10-08.
What interventions are being tested in trial NCT03821675?
The interventions under investigation include: Electrical Stimulation - Sham (DEVICE), Electrical Stimulation - Active (DEVICE).
Who is sponsoring clinical trial NCT03821675?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.